AGP Executive Report
Last update: 8 hours agoGene Therapy Milestone: Royal Medical Services says Bahraini patient Lujain has been discharged after successful Casgevy gene-editing treatment for sickle cell disease, marking another step in Bahrain’s inherited blood disorder programme. MS Care Spotlight: Bahrain’s first MS centre in the Arabian Gulf, the NBB Multiple Sclerosis Centre, held World Multiple Sclerosis Day activities with patient art and lifestyle guidance, highlighting integrated neurology, nutrition, rehab and diagnostic support under one roof. Family Law Update: Bahrain’s Shura committees backed revisions to allow children of separated parents to meet in more child-friendly public venues like malls, cafés and play areas, aiming to reduce anxiety and keep visits focused on the child’s welfare. Ebola Travel Warning: WHO criticised travel restrictions on Uganda over Ebola as unnecessary and harmful to economies, urging countries to rely on public health measures instead. Vaccine R&D Boost: SK bioscience says it has licensed injectable rotavirus vaccine technology from the US CDC and is moving into process development ahead of clinical trials. Regional Health & Safety Context: Amid renewed Iran–US tensions, Kuwait reported one death and 63 injuries after an airport terminal was hit, while WHO and local health authorities continue to stress public health and preparedness.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.